Immage Biotherapeutics Corp Stock Market Capitalization
Immage Biotherapeutics Corp fundamentals help investors to digest information that contributes to Immage Biotherapeutics' financial success or failures. It also enables traders to predict the movement of Immage Stock. The fundamental analysis module provides a way to measure Immage Biotherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immage Biotherapeutics stock.
Immage |
Immage Biotherapeutics Corp Company Market Capitalization Analysis
Immage Biotherapeutics' Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Immage Biotherapeutics Market Capitalization | 151 |
Most of Immage Biotherapeutics' fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immage Biotherapeutics Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of Immage Biotherapeutics Corp is about 151. This is much higher than that of the sector and significantly higher than that of the Market Capitalization industry. The market capitalization for all United States stocks is notably lower than that of the firm.
Immage Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immage Biotherapeutics' direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Immage Biotherapeutics could also be used in its relative valuation, which is a method of valuing Immage Biotherapeutics by comparing valuation metrics of similar companies.Immage Biotherapeutics is currently under evaluation in market capitalization category among its peers.
Immage Fundamentals
Return On Equity | -11.34 | |||
Return On Asset | -4.96 | |||
Current Valuation | 32.93 K | |||
Shares Outstanding | 151.74 M | |||
Shares Owned By Insiders | 69.85 % | |||
Price To Earning | (0.01) X | |||
EBITDA | (1.82 M) | |||
Net Income | (216.48 K) | |||
Cash And Equivalents | 53.69 K | |||
Debt To Equity | 2.52 % | |||
Current Ratio | 0.83 X | |||
Cash Flow From Operations | (215.82 K) | |||
Earnings Per Share | (0.01) X | |||
Beta | 56.14 | |||
Market Capitalization | 151 | |||
Total Asset | 243.1 K | |||
Working Capital | 17 K | |||
Current Asset | 75 K | |||
Current Liabilities | 58 K | |||
Z Score | -24.62 | |||
Net Asset | 243.1 K |
About Immage Biotherapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immage Biotherapeutics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immage Biotherapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immage Biotherapeutics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Immage Stock
If you are still planning to invest in Immage Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Immage Biotherapeutics' history and understand the potential risks before investing.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |